Literature DB >> 23265327

2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Andrew E Epstein, John P DiMarco, Kenneth A Ellenbogen, N A Mark Estes, Roger A Freedman, Leonard S Gettes, A Marc Gillinov, Gabriel Gregoratos, Stephen C Hammill, David L Hayes, Mark A Hlatky, L Kristin Newby, Richard L Page, Mark H Schoenfeld, Michael J Silka, Lynne Warner Stevenson, Michael O Sweeney, Cynthia M Tracy, Andrew E Epstein, Dawood Darbar, John P DiMarco, Sandra B Dunbar, N A Mark Estes, T Bruce Ferguson, Stephen C Hammill, Pamela E Karasik, Mark S Link, Joseph E Marine, Mark H Schoenfeld, Amit J Shanker, Michael J Silka, Lynne Warner Stevenson, William G Stevenson, Paul D Varosy.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23265327     DOI: 10.1016/j.jacc.2012.11.007

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  246 in total

1.  Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.

Authors:  Samir Saba; Josef Marek; Mian Bilal Alam; Evan Adelstein; David Schwartzman; Sandeep Jain; John Gorcsan
Journal:  J Interv Card Electrophysiol       Date:  2014-11-13       Impact factor: 1.900

2.  Periprocedural management of cardiac resynchronization therapy.

Authors:  John Rickard; Niraj Varma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

Review 3.  The role of cardiac pacing in carotid sinus syndrome: a meta-analysis.

Authors:  Bing-Wei Chen; Zhi-Guang Wang; Na-Qiang Lv; Yan-Mei Cheng; Ai-Min Dang
Journal:  Clin Auton Res       Date:  2014-03-29       Impact factor: 4.435

4.  Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.

Authors:  Larisa G Tereshchenko; Alan Cheng; Jason Park; Nicholas Wold; Timothy E Meyer; Michael R Gold; Suneet Mittal; Jagmeet Singh; Kenneth M Stein; Kenneth A Ellenbogen
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

Review 5.  Alzheimer's disease: the impact of age-related changes in reproductive hormones.

Authors:  C S Atwood
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

6.  Arrhythmias: Changing indications for biventricular pacing in bradycardia.

Authors:  S Serge Barold
Journal:  Nat Rev Cardiol       Date:  2013-06-11       Impact factor: 32.419

7.  Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.

Authors:  Selcuk Adabag; Kristen K Patton; Alfred E Buxton; Thomas S Rector; Kristine E Ensrud; Kairav Vakil; Wayne C Levy; Jeanne E Poole
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

8.  The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.

Authors:  Aya Miyazaki; Heima Sakaguchi; Hideo Ohuchi; Kenji Yasuda; Nobuyuki Tsujii; Michio Matsuoka; Tetsuya Yamamoto; Satoshi Yazaki; Etsuko Tsuda; Osamu Yamada
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

9.  Implanted endocardial lead characteristics and risk of stroke or transient ischemic attack.

Authors:  Vaibhav R Vaidya; Christopher V DeSimone; Samuel J Asirvatham; Vishnu M Chandra; Amit Noheria; David O Hodge; Joshua P Slusser; Alejandro A Rabinstein; Paul A Friedman
Journal:  J Interv Card Electrophysiol       Date:  2014-04-27       Impact factor: 1.900

Review 10.  Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.

Authors:  Peggy M Kostakou; Nikos T Kouris; Vassilios S Kostopoulos; Dimitrios S Damaskos; Christoforos D Olympios
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.